Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Ethnopharmacol ; 271: 113805, 2021 May 10.
Article in English | MEDLINE | ID: mdl-33465442

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Syzygium cumini (L.) Skeels is an important medicinal plant utilized in the health care systems of Pakistan, India, Sri Lanka, and Bangladesh. S. cumini have been used to treat renal issues, indigestion, diabetes, dysentery, and employed in folk medicine to treat inflammations. It is known to anticipate antioxidant, anti-inflammatory, anticancer, anti-diabetic, anti-bacterial, antifungal, activities, and radioprotective activities. MATERIAL AND METHODS: We examined the in vitro anti-inflammatory activities of S. cumini fruit extracts, evaluated using membrane stabilization, egg albumin denaturation, and bovine serum albumin denaturation assays. In vivo anti-inflammatory activity was also assessed, using murine models of carrageenan, formaldehyde, and PGE2 induced paw edema. Fractionation of active extracts was performed using HPLC, followed by LC-ESI-MS/MS analysis to identify the bioactive compounds responsible for anti-inflammatory activity. RESULTS: The crude methanolic extract showed stronger in vitro and in vivo anti-inflammatory activities compared to other extracts. The most potent effects were observed in the formaldehyde induced paw edema assay wherein methanolic extract and standard indomethacin induced 72% and 88% inhibition against paw edema volume in comparison to control (normal saline) respectively. In the bovine serum albumin denaturation assay the methanolic extract induced 82% inhibition against denaturation as compared to control (phosphate buffer) while standard diclofenac sodium induced 98% inhibition. In contrast, 50% v/v MeOH:H2O or 100% dichloromethane extracts displayed moderate to weak effects in the anti-inflammatory models. HPLC fractionation provided 6 active sub-fractions, four (MF2, MF3, MF6, MF7) from the 100% methanolic extract and two (HAF1, HAF3) from the 50% methanolic extract. The MF2, MF7, and HAF1 sub-fractions displayed potent activity in all studied in vitro assays. LC-ESI-MS-MS analysis tentatively identified delphinidin 3-glucoside, peonidin-3,5-diglucoside, gallic acid, liquitrigenin, scopoletin, umbelliferon, and rosmanol from the 100% methanolic fractions. Myricetin, catechin, quinic acid, chlorogenic acid, ellagic acid, gallic acid, and caffeic acid were identified in the 50% methanolic fractions. CONCLUSIONS: These results demonstrate that S. cumini fruit extracts are a rich source of bioactive compounds that are worthy of further investigation as leads for anti-inflammatory drug discovery.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Edema/drug therapy , Plant Extracts/pharmacology , Syzygium/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Antioxidants/chemistry , Antioxidants/therapeutic use , Asia , Disease Models, Animal , Edema/chemically induced , Foot Injuries/chemically induced , Foot Injuries/drug therapy , Foot Injuries/pathology , Fruit/chemistry , In Vitro Techniques , Medicine, Traditional , Mice , Phytochemicals/analysis , Phytochemicals/chemistry , Plant Extracts/therapeutic use , Rats, Wistar
2.
Pediatr Emerg Care ; 35(12): e234-e235, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30702643

ABSTRACT

We present an illustrative case of unintentional burns to the feet of a 15-month-old child following the application of raw garlic as a home remedy for fever. We provide an overview of the historical medicinal uses of garlic as well as its unintended adverse effects. This case underscores the importance of clinicians' ability to recognize unusual presentations of injury due to culturally based practices that require care in emergency settings. This is particularly important in patient populations for whom abusive etiology would be considered.


Subject(s)
Burns, Chemical/pathology , Fever/therapy , Foot Injuries/chemically induced , Garlic/adverse effects , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Bacitracin/administration & dosage , Bacitracin/therapeutic use , Bandages/standards , Burns, Chemical/drug therapy , Burns, Chemical/etiology , Female , Fever/complications , Foot Injuries/pathology , Humans , Infant , Medicine, Traditional/adverse effects , Phenols/administration & dosage , Treatment Outcome
6.
J Oncol Pharm Pract ; 12(3): 131-41, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17022868

ABSTRACT

INTRODUCTION: Capecitabine (Xeloda) is a systemic prodrug of 5-fluorouracil (5-FU), which is administered in an oral formulation. Hand-foot syndrome (HFS) has proven to be a chronic dose-limiting toxicity of capecitabine, leading to significant morbidity in patients receiving this agent. The purpose of this review is to define the pathophysiology, risk factors, incidence and management of capecitabine-induced HFS. METHODS: Literature for this review article was collected from the following databases: PubMed, CINAHL, and the proceedings of the American Society of Clinical Oncology (ASCO) confined to the years 1995-2006. The following key terms were used in the search: hand-foot syndrome, palmar-plantar erythrodysesthesia, capecitabine, Xeloda, colorectal cancer, and metastatic breast cancer. RESULTS: HFS associated with capecitabine is a serious dose-limiting toxicity. Incidence of grade 3/4 toxicity is of extreme significance, and introduces the need for dose reductions and/or interruptions in capecitabine therapy. Drug-related therapies studied include topical emollients and creams, systemic and topical corticosteroids, nicotine patch, vitamin E, pyridoxine, and COX-2 inhibitors. However, due to the lack of randomized, controlled trials with these therapies, the current mainstay of treatment for the management of this toxicity is interruption of therapy and, if necessary, dose reduction. CONCLUSION: Treatment interruption or dose reduction remain the only methods shown to effectively manage HFS, but supportive measures to reduce pain and discomfort and prevent secondary infection are very important. Many other prophylactic and treatment strategies have been investigated, with pyridoxine and COX-2 inhibitors being the most promising in case reports and retrospective studies; therefore, prospective, randomized, controlled trials are needed to prove their efficacy.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Deoxycytidine/analogs & derivatives , Fluorouracil/analogs & derivatives , Paresthesia/chemically induced , Antimetabolites, Antineoplastic/therapeutic use , Capecitabine , Deoxycytidine/adverse effects , Fluorouracil/adverse effects , Foot Injuries/chemically induced , Foot Injuries/pathology , Hand Injuries/chemically induced , Hand Injuries/pathology , Humans , Syndrome
7.
Immunopharmacol Immunotoxicol ; 28(3): 397-410, 2006.
Article in English | MEDLINE | ID: mdl-16997789

ABSTRACT

This study was aimed to evaluate the therapeutic potency of a new antimalarial drug, artesunate, in an experimental model of rheumatoid arthritis. Collagen-induced arthritis (CIA) was induced in Lewis rats.The intraperitoneally administration of artesunate (ARS) and methotrexate (MTX) were started on day 25 postimmunization and continued until final assessment on day 35. During this period, clinical examination was intermittent. The anticollagen type II antibody (CII Ab) and nitric oxide synthesis were measured. The paws and kness were then removed for histopathology and radiography assay. The biocompatibility of ARS and MTX were assessed using fibrosarcoma cell line. Our results showed that i.p. injection of artesunate to arthritic rats induced a significant reduction in paw edema. This beneficial effect was associated with a significant decrease in anti-CII antibody response compared with untreated rats. Histopathological assessment showed reduced inflammatory cells infiltrate in joints of treated rats, and tissue edema and bone erosion in the paws were markedly reduced following ARS therapy. Moreover, our radiographic results paralleled histological findings. Cytotoxicity analysis of ARS showed greater tolerability compared with MTX. Treatment with ARS significantly diminished nitric oxide formation in treated rats compared with untreated controls. Our findings revealed the therapeutic efficacy of artesunate in experimental rheumatoid arthritis compared with a choice drug (methotrexate). This result may recommend it as a second-line drug in the treatment of rheumatoid arthritis.


Subject(s)
Artemisinins/therapeutic use , Arthritis, Experimental/drug therapy , Sesquiterpenes/therapeutic use , Animals , Artemisinins/administration & dosage , Artesunate , Arthritis, Experimental/immunology , Arthritis, Experimental/metabolism , Autoantibodies/analysis , Cell Line, Tumor , Cell Survival/drug effects , Collagen Type II/immunology , Collagenases/metabolism , Edema/chemically induced , Edema/drug therapy , Edema/immunology , Foot Injuries/chemically induced , Foot Injuries/drug therapy , Foot Injuries/immunology , Hindlimb/diagnostic imaging , Hindlimb/injuries , Hindlimb/ultrastructure , Humans , Inflammation/chemically induced , Inflammation/immunology , Inflammation/pathology , Injections, Intradermal , Injections, Intraperitoneal , Male , Matrix Metalloproteinase Inhibitors , Methotrexate/administration & dosage , Methotrexate/therapeutic use , Nitric Oxide/metabolism , Radiography , Rats , Rats, Inbred Lew , Sesquiterpenes/administration & dosage , Time Factors
8.
Br J Pharmacol ; 148(5): 688-95, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16702985

ABSTRACT

1. The present study evaluated the participation of tumour necrosis factor-alpha (TNF-alpha) in the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. 2. The intraplantar injection of carrageenan (300 microg paw-1) induced a marked and biphasic paw oedema formation (peaks at 6 and 72 h), which was accompanied by a long-lasting mechanical allodynia (that remained elevated for up to 72 h) and a significant increase of myeloperoxidase (MPO) activity (peak at 6 h) in both Swiss and C57/BL6 mice. 3. The paw oedema, the elevation of MPO activity and to a lesser extent the mechanical allodynia elicited by carrageenan were found to be significantly reduced in TNF-alpha p55 receptor knockout mice. 4. Of interest, the systemic administration of an anti-TNF-alpha antibody produced a significant inhibition of paw oedema, mechanical allodynia and MPO activity. A noteworthy decrease in inflammatory and nociceptive responses caused by carrageenan was also observed when mice were previously treated with the preferential inhibitor of TNF-alpha synthesis, thalidomide. 5. The present results clearly indicate that the proinflammatory cytokine TNF-alpha plays a critical role in the oedema formation, as well as in the mechanical allodynia and the neutrophil migration, following carrageenan administration into the mouse paw. Intraplantar injection of carrageenan in mice could constitute a useful model for assessment of the in vivo effects of potential inhibitors of TNF-alpha-related pathways.


Subject(s)
Carrageenan/pharmacology , Foot Injuries/chemically induced , Inflammation/chemically induced , Pain Measurement/drug effects , Tumor Necrosis Factor-alpha/physiology , Animals , Edema/chemically induced , Foot/physiology , Foot Diseases/chemically induced , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Pain/chemically induced , Peroxidase/metabolism , Tumor Necrosis Factor-alpha/metabolism
9.
Ann Plast Surg ; 54(6): 664-6, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15900157

ABSTRACT

Extravasation injury is a common event in pediatric intensive-care units. This is the first report of successful utilization of the prepuce as a skin graft to reconstruct a full thickness skin necrosis due to a phenobarbital extravasation to the forefoot of a newborn.


Subject(s)
Anticonvulsants/adverse effects , Foot Injuries/surgery , Phenobarbital/adverse effects , Skin Transplantation/methods , Skin/pathology , Anticonvulsants/administration & dosage , Circumcision, Male , Foot Injuries/chemically induced , Humans , Infant, Newborn , Infusions, Intravenous , Male , Necrosis/chemically induced , Penis/surgery , Phenobarbital/administration & dosage , Seizures/drug therapy , Seizures/etiology , Stroke/complications
11.
Contact Dermatitis ; 45(2): 68-71, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11553114

ABSTRACT

We review the literature on cement burns of the skin published during the last 4 decades. 51 case reports were analyzed with special regard to common modes of injury, localization of cement exposure, preventive measures taken and treatment. Cement burns are injuries concerning professionals at the workplace as well as amateurs during do-it-yourself work. In 49% of the cases, no attempt to protect the skin had been made. The majority of injuries were located on the lower legs and knees. Full-thickness burns were reported in 66% of cases. Surgery had to be performed in 34%. Cement burns can be avoided by adequate skin protection. Although acute cement injuries may seem rare, prospective studies should be carried out for correct estimation of prevalence. The need for information on the harmful properties of cement in the occupational as well as the domestic environment is emphasized.


Subject(s)
Burns, Chemical/epidemiology , Burns, Chemical/etiology , Caustics/adverse effects , Construction Materials/adverse effects , Occupational Diseases/epidemiology , Occupational Diseases/etiology , Skin/injuries , Adult , Burns, Chemical/pathology , Burns, Chemical/prevention & control , Burns, Chemical/surgery , Caustics/chemistry , Female , Foot Injuries/chemically induced , Foot Injuries/epidemiology , Germany/epidemiology , Humans , Injury Severity Score , Leg Injuries/chemically induced , Leg Injuries/epidemiology , Male , Occupational Diseases/pathology , Occupational Diseases/prevention & control , Occupational Diseases/surgery , Protective Clothing , Skin Transplantation
13.
J Accid Emerg Med ; 14(6): 401-2, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9413783

ABSTRACT

An effective method of providing pain relief in hydrofluoric acid burns is reported, using a Bier's block type technique and regional intravenous calcium gluconate. This method allows satisfactory analgesia and prevents further tissue destruction, without the risk and added discomfort of increased tissue tensions associated with local infiltration of calcium.


Subject(s)
Burns, Chemical/drug therapy , Calcium Gluconate/therapeutic use , Hydrofluoric Acid , Adult , Female , Finger Injuries/chemically induced , Foot Injuries/chemically induced , Humans , Male , Nerve Block
SELECTION OF CITATIONS
SEARCH DETAIL
...